Alger Associates, Inc. 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:18 pm Purchase |
2024-12-31 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 1,133,944 17.700% |
175,019 (+18.25%) |
Filing |
| 2024-12-06 4:05 pm Purchase |
2024-11-30 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 958,925 15.000% |
876,227 (+1059.55%) |
Filing |
| 2024-11-14 4:02 pm Purchase |
2024-09-30 | 13G | Forte Biosciences, Inc. FBRX |
Alger Associates, Inc. | 82,698 5.700% |
82,698 (New Position) |
Filing |